SCHEMBL30306035

SCHEMBL30306035

C=CC(=O)Nc1ccc(-c2c(-c3ccc(Oc4nccc(C)n4)c(F)c3)c(C(N)=O)nn2C)cc1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.54
▸ CYP2D6 P10635 1/20 0.54
▸ FGFR1 P11362 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ FGFR2 P21802 1/20 0.54
▸ FGFR4 P22455 1/20 0.54
▸ FGFR3 P22607 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ BRD4 O60885 5/20 0.41
▸ EGFR P00533 6/20 0.41
▸ GRM5 P41594 2/20 0.38
▸ MAPK10 P53779 4/20 0.38
▸ MAPK14 Q16539 4/20 0.38
▸ MET P08581 1/20 0.35
▸ AXL P30530 1/20 0.35
▸ ERBB2 P04626 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29002680 1.00 CYP3A4 (0.54) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL29002655 0.87 FGFR4 (0.46) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL30306033 0.86 CYP3A4 (0.50) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL29002697 0.86 CYP3A4 (0.50) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL29002652 0.83 FGFR4 (0.47) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL30306046 0.83 FGFR4 (0.47) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL29002667 0.82 CYP3A4 (0.46) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL30306049 0.82 CYP3A4 (0.46) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL30736133 0.81 FGFR4 (0.49) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL24773303 0.81 FGFR4 (0.58) CYP3A4CYP2D6FGFR1CYP2C9FGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115772161-A Nitrogen-containing heteroaryl compound, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2023-03-10 — — CN disclosed
Send feedback